ARCHIVES

In Brief: Bruce Chamber Is DeVita’s Choice as Permanent Director Of DCT; Six New RCDAs Funded In FY 1982

This article is from The Cancer Letter archive.

Vol. 08 No. 24 | June 11, 1982

Download PDF Visit The Full Archive

Related Articles

Broad Institute wins NIH grant for first national SNP genotyping center.

October 8, 2004

Clinical Trials Approved By NCI Last Month Are Listed

January 25, 2002

DCT Board Insists On Being Heard In Development Of CCOP Guidelines

February 19, 1982

MDV3100 Improves Survival, Reduces Death Risk by 37%

November 25, 2011

In Brief: Reducing Doses Cuts Cure Rate Every Time, DeVita Says; Hyperthermia Use In Cancer Being Assessed

April 6, 1984

In Brief: Stoval to Receive ACCC Award; Groopman, Sigal, Named to Board of Scientific Advisors

March 12, 1999